Agno Pharma, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is POLIDOCANOL, with a corresponding US DMF Number 37637.
Remarkably, this DMF maintains an Active status since its submission on June 17, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 08, 2024, and payment made on October 31, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II